📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Insulet Corp

Common Name
Insulet
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
3,900
Ticker
PODD
Exchange
NASDAQ/NGS
Description
Insulet Corporation is a leading medical device company specializing in innovative insulin management systems for people with diabetes. Founded in 2000 and headquartered in Acton, Massachusetts, Insul...

Insulet's GHG Emissions Data Preview

In 2024, Insulet completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Insulet has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=PODD&reporting_period=2024"

Verified Sources Behind Insulet’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Insulet’s data sources below and access millions more through our Disclosure Search.

a. Insulet's ESG Data Spreadsheet 2024
a. Insulet's ESG Data Spreadsheet 2024
b. Insulet's ESG Data Spreadsheet 2021
b. Insulet's ESG Data Spreadsheet 2021

Insights into Insulet's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions ofInsulet amounted to12,440metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Insuletincreased by 154.4%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Insulet's Scope 1 Emissions Over Time

2020202120222023202404509001.35 k1.8 ktCO2e-17%+3%-10%+5%
  • Total Scope 1
  • Year-over-Year Change

What are Insulet's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Insulet were 1,383 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

Has Insulet reduced its Scope 1 emissions over time?

Since 2020, Insulet's Scope 1 emissions have decreased by 19.08%, reflecting a declining long-term trend in Scope 1 emissions over time.ab

Compared to the previous year(2023), Insulet's Scope 1 emissions increased by 5.09%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Insulet's Scope 2 emissions?

In 2024, Insulet reported Scope 2 greenhouse gas (GHG) emissions of 11,467 tCOâ‚‚e using the market-based method and 11,057 tCOâ‚‚e using the location-based method.a

Has Insulet reduced its Scope 2 emissions over time?

Since 2020, Insulet's Scope 2 greenhouse gas (GHG) emissions (Location-Based)have increased by 386.45%, reflecting a rising long-term trend in Scope 2 emissions over time.ab

Compared to the previous year(2023), Insulet's Scope 2 emissions(Location-Based) rose by 209.37% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya

What methodology does Insulet use for Scope 2 reporting?

In 2024, Insulet reported its Scope 2 emissions using the market-based method and using the location-based method.a

Insulet's Scope 2 Emissions Over Time

2020202120222023202403 k6 k9 k12 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Insulet’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Insulet reported Scope 1 greenhouse gas (GHG) emissions of 1,383 tCOâ‚‚e and total revenues of USD 2,072 millions. This translates into an emissions intensity of 0.67 tCOâ‚‚e per millions USD.a

Insulet's Scope 1 Emissions Intensity Compared to Peers

205005,000100,0002,000,000Scope 1 Emissions (tCO2e)1005005,00020,000100,000Revenues (Millions of USD)IInteger HoldingsYear: 2023Scope 1: 7,066 tCO2eRevenue: $M 1,597Scope 1 Intensity: 4.43 tCO2e/$MEnovisYear: 2024Scope 1: 2,321 tCO2eRevenue: $M 2,108Scope 1 Intensity: 1.10 tCO2e/$MBio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$MAbbott LaboratoriesYear: 2024Scope 1: 502,000 tCO2eRevenue: $M 41,950Scope 1 Intensity: 11.97 tCO2e/$MBio Rad LaboratoriesYear: 2023Scope 1: 10,563 tCO2eRevenue: $M 2,671Scope 1 Intensity: 3.95 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MEdwards LifesciencesYear: 2024Scope 1: 15,682 tCO2eRevenue: $M 5,439Scope 1 Intensity: 2.88 tCO2e/$MMettler-Toledo InternationalYear: 2024Scope 1: 27,797 tCO2eRevenue: $M 3,872Scope 1 Intensity: 7.18 tCO2e/$MGlaukosYear: 2024Scope 1: 523 tCO2eRevenue: $M 383Scope 1 Intensity: 1.36 tCO2e/$MBrukerYear: 2022Scope 1: 3,621 tCO2eRevenue: $M 2,531Scope 1 Intensity: 1.43 tCO2e/$MAgilent TechnologiesYear: 2024Scope 1: 29,698 tCO2eRevenue: $M 6,510Scope 1 Intensity: 4.56 tCO2e/$MWatersYear: 2023Scope 1: 12,660 tCO2eRevenue: $M 2,956Scope 1 Intensity: 4.28 tCO2e/$MStrykerYear: 2023Scope 1: 54,854 tCO2eRevenue: $M 20,498Scope 1 Intensity: 2.68 tCO2e/$MVeeva SystemsYear: 2024Scope 1: 264 tCO2eRevenue: $M 2,747Scope 1 Intensity: 0.10 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MZimmer Biomet HoldingsYear: 2024Scope 1: 10,191 tCO2eRevenue: $M 7,679Scope 1 Intensity: 1.33 tCO2e/$MIDEXX LaboratoriesYear: 2024Scope 1: 18,461 tCO2eRevenue: $M 3,898Scope 1 Intensity: 4.74 tCO2e/$MAvanos MedicalYear: 2023Scope 1: 1,787 tCO2eRevenue: $M 673Scope 1 Intensity: 2.65 tCO2e/$MIIIntegra Lifesciences HoldingsYear: 2024Scope 1: 14,555 tCO2eRevenue: $M 1,611Scope 1 Intensity: 9.04 tCO2e/$MDexcomYear: 2024Scope 1: 8,328 tCO2eRevenue: $M 4,033Scope 1 Intensity: 2.07 tCO2e/$MBoston ScientificYear: 2024Scope 1: 87,567 tCO2eRevenue: $M 16,747Scope 1 Intensity: 5.23 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MInsuletYear: 2024Scope 1: 1,383 tCO2eRevenue: $M 2,072Scope 1 Intensity: 0.67 tCO2e/$M

How does Insulet's GHG emissions intensity compare to its peers?

In 2024, Insulet reported a Scope 1 emissions intensity of 0.67 tCOâ‚‚e per millions USD. Compared to the peer group median of 2.88, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Insulet rank on GHG emissions intensity within its industry?

In 2024, Insulet ranked 3 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a

This places Insulet among the top performers, with one of the lowest emissions intensities relative to peers.a

Want Full Access to Insulet's GHG Emissions Dataset?
Sign Up